Mimedx (MDXG) Long-Term Deferred Tax (2015 - 2026)

Mimedx's Long-Term Deferred Tax history runs 7 years deep, the most recent figure standing at $24.1 million for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax fell 12.85% year-over-year to $24.1 million; the TTM figure through Mar 2026 stood at $24.1 million (down 12.85% YoY), while the FY2025 annual figure was $19.6 million, down 30.77% from the prior year.
• Long-Term Deferred Tax came in at $24.1 million for Q1 2026 at Mimedx, up from $19.6 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $40.8 million in Q4 2023 to a low of $19.6 million in Q4 2025.
• A 4-year average of $29.2 million and a median of $28.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax tumbled 30.77% in 2025 and decreased 12.85% in 2026, its largest moves.
• Mimedx's Long-Term Deferred Tax stood at $40.8 million in 2023, then sank by 30.58% to $28.3 million in 2024, then sank by 30.77% to $19.6 million in 2025, then increased by 23.12% to $24.1 million in 2026.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $24.1 million, $19.6 million, and $21.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison